Catalyst Pharmaceutical Partners Inc buy Cantor Fitzgerald
Start price
06.06.25
/
50%
€22.79
Target price
06.06.26
-
Performance (%)
17.16%
End price
07.06.26
€26.70
Summary
This prediction ended on 07.06.26 with a price of €26.70. The BUY prediction by Cantor_Fitzgerald finished with a performance of 17.16%. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Catalyst Pharmaceutical Partners Inc | 1.115% | 1.115% | 19.824% |
| iShares Core DAX® | -2,49 % | 0,32 % | 0,75 % |
| iShares Nasdaq 100 | -4,40 % | 1,59 % | 32,09 % |
| iShares Nikkei 225® | -4,29 % | 0,97 % | 50,00 % |
| iShares S&P 500 | -2,20 % | 2,00 % | 22,60 % |
Comments by Cantor_Fitzgerald for this prediction
In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.
Ratings data for CPRX provided by MarketBeat
In the thread Trading Catalyst Pharmaceutical Partners Inc
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Cantor_Fitzgerald for Catalyst Pharmaceutical Partners Inc
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€14.55
22.03.24
22.03.24
€31.46
22.03.25
22.03.25
64.12%
23.03.25
23.03.25
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€16.00
01.03.24
01.03.24
€31.37
01.03.25
01.03.25
39.63%
02.03.25
02.03.25